Simulations Plus Inc
SLP14.090USD
-0.480-3.29%
交易中 （美东）报价延迟15分钟
219.42M总市值
亏损市盈率 TTM
关于 Simulations Plus Inc 公司
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Simulations Plus Inc简介
公司代码SLP
公司名称Simulations Plus Inc
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)
员工数量212
证券类型Ordinary Share
年结日Jun 18
公司地址800 Park Offices Drive, Suite 401
城市RESEARCH TRIANGLE PARK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27709
电话16617237723
网址https://www.simulations-plus.com/
公司代码SLP
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)
Simulations Plus Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.28M
+1776.00%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+8950.00%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
15.06K
+1776.00%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
12.47K
+1776.00%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Lisa Lavange
Dr. Lisa Lavange
Independent Director
Independent Director
--
--
Mr. William (Will) Frederick
Mr. William (Will) Frederick
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Jonathan Chauvin
Dr. Jonathan Chauvin
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.28M
+1776.00%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+8950.00%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
15.06K
+1776.00%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
12.47K
+1776.00%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Software licenses
45.83M
57.88%
Consulting services
33.35M
42.12%
地区USD
名称
营收
占比
Americas
57.70M
72.87%
Europe
14.19M
17.92%
Asia
7.29M
9.20%
业务
地区
业务USD
名称
营收
占比
Software licenses
45.83M
57.88%
Consulting services
33.35M
42.12%
股东统计
更新时间: 2月5日 周四
更新时间: 2月5日 周四
持股股东
股东类型
持股股东
持股股东
占比
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
5.02%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
其他
65.47%
持股股东
持股股东
占比
Woltosz (Walter S)
16.28%
BlackRock Institutional Trust Company, N.A.
5.29%
The Vanguard Group, Inc.
5.02%
Morgan Stanley & Co. LLC
4.13%
First Light Asset Management, LLC
3.81%
其他
65.47%
股东类型
持股股东
占比
Investment Advisor
36.70%
Investment Advisor/Hedge Fund
22.17%
Individual Investor
17.33%
Hedge Fund
10.72%
Research Firm
8.85%
Pension Fund
0.49%
Bank and Trust
0.21%
Venture Capital
0.11%
Insurance Company
0.03%
其他
3.38%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
414
15.97M
79.29%
-4.03M
2025Q3
399
15.45M
76.77%
-3.13M
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
2023Q3
390
19.23M
96.46%
-1.16M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Woltosz (Walter S)
3.28M
16.28%
-9.10K
-0.28%
Dec 18, 2025
BlackRock Institutional Trust Company, N.A.
1.06M
5.29%
-1.18M
-52.66%
Sep 30, 2025
The Vanguard Group, Inc.
974.48K
4.84%
-197.15K
-16.83%
Sep 30, 2025
Morgan Stanley & Co. LLC
832.51K
4.13%
+582.97K
+233.61%
Sep 30, 2025
First Light Asset Management, LLC
767.76K
3.81%
+410.60K
+114.96%
Sep 30, 2025
Rockefeller Capital Management
745.96K
3.7%
+366.80K
+96.74%
Sep 30, 2025
Columbia Threadneedle Investments (UK)
602.47K
2.99%
+884.00
+0.15%
Sep 30, 2025
Tributary Capital Management, LLC
568.49K
2.82%
+207.21K
+57.36%
Sep 30, 2025
Stephens Investment Management Group, LLC
392.84K
1.95%
+124.26K
+46.27%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
410.85K
2.04%
-74.55K
-15.36%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
State Street SPDR FactSet Innovative Technolgy ETF
0.58%
Global X HealthTech ETF
0.31%
First Trust Active Factor Small Cap ETF
0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
0.21%
Franklin Exponential Data ETF
0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.09%
Principal U.S. Small-Cap ETF
0.07%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
查看更多
State Street SPDR FactSet Innovative Technolgy ETF
占比0.58%
Global X HealthTech ETF
占比0.31%
First Trust Active Factor Small Cap ETF
占比0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.21%
Franklin Exponential Data ETF
占比0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
占比0.09%
Principal U.S. Small-Cap ETF
占比0.07%
iShares Micro-Cap ETF
占比0.06%
iShares Russell 2000 Growth ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.01%
分红派息
近5年累计派现
19.26M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
查看更多
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
